Imagen de Portada
Código QR

Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations.

Publicado en:Lancet Vol. 354; no. 9188; pp. 1457 - 1464
Autores principales: Hankey GJ, Warlow CP
Formato: tables/charts Journal Article
Publicado: Lancet 10/23/1999
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=107088719&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 107088719
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        01406736
        LAN
      jtl: Lancet
      issn: 01406736
      maglogo: N
    pubinfo:
      dt: 10/23/1999
      vid: 354
      iid: 9188
      pid: 1297
      pub: Lancet
      place: Philadelphia, Pennsylvania
    artinfo:
      ui:
        107088719
        107088719
        2000011079
        10.1016/s0140-6736(99)04407-4
        NLM10543686
        107088719
      ppf: 1457
      ppct: 7
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations.
      aug:
        au:
          Hankey GJ
          Warlow CP
        affil: Stroke Unit, Department of Neurology, Royal Perth Hospital, Wellington St., Perth, Western Australia 6001; e-mail: gjhankey@cyliene.uwa.edu.au
      sug:
        subj:
          Stroke Prevention and Control
          Stroke Drug Therapy
          Treatment Outcomes
          Cost Benefit Analysis
          Systematic Review
          Clinical Trials
          Thrombolytic Therapy
          Hospital Units
          Risk Factors
          Aspirin Therapeutic Use
      pubtype: Academic Journal
      doctype:
        tables/charts
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N